Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model Bolesnici sa folikularnim limfomom, visokim FLIPI skorom i velikom tumorskom masom: model za odreivanje rizika

Background/Aim. The widely accepted Follicular Lym- phoma International Prognostic Index (FLIPI) divides pa- tients into three risk groups based on the score of adverse prognostic factors. The estimated 5-year survival in patients with a high FLIPI score is around 50%. The aim of this study was to analyse the prognostic value of clinical and laboratory parameters that are not included in the FLIPI and the New Prognostic Index for Follicular Lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project (FLIPI2) indices, in follicular lymphoma (FL) patients with a high FLIPI score and high tumor burden. Methods. The ret- rospective analysis included 57 newly diagnosed patients with FL, a high FLIPI score and a high tumor burden. All the pa- tients were diagnosed and treated between April 2000 and June 2007 at the Clinic for Hematology, Clinical Center of Serbia, Belgrade. Results. The patients with a histological grade > 1, erythrocyte sedimentation rate (ESR) i 45 mm/h and hypoalbuminemia had a significantly worse overall sur- vival (p = 0.015; p = 0.001; p = 0.008, respectively), while there was a tendency toward worse overall survival in the pa- tients with an Eastern Cooperative Oncology Group (ECOG) > 1 (p = 0.075). Multivariate Cox regression analysis identified a histological grade > 1, ESR i 45 mm/h and hy- poalbuminemia as independent risk factors for a poor out- come. Based on a cumulative score of unfavourable prognos- tic factors, patients who had 0 or 1 unfavourable factors had a significantly better 5-year overall survival compared to patients with 2 or 3 risk factors (75% vs 24.1%, p = 0.000). Conclu- sion. The obtained results suggest that from the examined prognostic parameters histological grade > 1, ESR i 45 mm/h and hypoalbuminemia can contribute in defining pa- tients who need more aggressive initial treatment approach, if two or three of these parameters are present on presentation.